Startseite Themen Brennpunkt INNOVATIONSPREIS-IT IT-Bestenliste INDUSTRIEPREIS INDUSTRIE-Bestenliste TrafficGenerator
INNOVATIONSPREIS-IT 2017

Drucken
Mittelstandspresse

11.11.2019

Analysis of N-Nitrosodimethylamine (NDMA) – Impurities in Ranitidine

Testing at Adamson Analytical Laboratories

Adamson Analytical Laboratories
Adamson Analytical Laboratories

Corona, CA (USA), 11.11.2019 (PresseBox) - In September 2019, the U.S. Food and Drug Administration (FDA) published a statement of NDMA found in samples of ranitidine, a drug used to treat peptic ulcer disease, gastroesophageal reflux disease and Zollinger-Ellison syndrome.

NDMA is a substance from the class of compounds known as Nitrosamines and is well documented to be an environmental contaminant found in water and foods, including various meats, dairy products, and vegetables.

Samples tested positive for NDMA residues

In late September 2019, the FDA alerted health care professionals and patients to a voluntary recall of ranitidine medicines. Nevertheless, it turned out that some methods for the detection of NDMA residues were using elevated temperatures which induced the artificial synthesis of NDMA.

In November 2019, the FDA published a list of laboratory results of NDMA in ranitidine and nizatidine products that clearly showed all samples tested positive for NDMA residues. Although detectable levels of NDMA were found in each sample, the concentration varied significantly between the different products. The FDA has set the acceptable daily intake limit for NDMA at 0.096 micrograms or 0.32 ppm for ranitidine – which is exceeded by several products tested.

Other countries and agencies are reviewing this issue as well – e.g. in September 2019 the European Medicines Agency (“EMA to review ranitidine medicines following detection of NDMA” or in October 2019 the Mexican Federal Commission for the Protection against Sanitary Risks (COFEPRIS) “La Cofepris informa sobre los productos que contienen dentro de su formulación al principio activo Ranitidina”.

Testing of possible NDMA impurities at Adamson Analytical Laboratories

The Tentamus Lab “Adamson Analytical Laboratories”, based in Corona, CA is proud to offer the testing of possible NDMA impurities in your product. Adamson has developed a method that does not require any heating of the sample, thus eliminating any risk of false positives from heat treatment during the analysis of your product.

As it is vital to obtain the necessary data in short time, Adamson Analytical Laboratories guarantee a maximum turnaround time of 3 business days at a very competitive price of $185. 

At Adamson Analytical, we aim to be your go-to laboratory for all your testing needs.

 

Ansprechpartner

Tobias Wiezorek
+1 (951) 549-9657
Zuständigkeitsbereich: CEO Tentamus California

Über Tentamus Group GmbH:

Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China, Japan, India and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrosciences, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 65 locations worldwide. More than 2,500 highly-trained staff members work in over 2.5 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.

Tentamus Group

An der Industriebahn 5

13088 Berlin, Germany

www.tentamus.com

Datei-Anlagen:


(177 kB)
0988069.attachment

Adamson Analytical Laboratories